Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immutep Ltd (PRRUF)
OTHER OTC:PRRUF
Immutep Ltd (PRRUF) Stock Price & Analysis
15 Followers
PRRUF Stock Chart & Stats
Day’s Range$0.24 - $0.24
52-Week Range― - ―
Previous Close$0.25
Volume3.00K
Average Volume (3M)N/A
Market Cap
$265.44M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Aug 28, 2024EPS Estimate
-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.49Price Target Upside104.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Immutep Ltd News
PremiumCompany Announcements
Immutep’s Promising Trial Results for Cancer Therapy
PremiumCompany Announcements
Immutep Advances Novel Autoimmune Therapy with Phase I TrialPremiumCompany Announcements
Immutep Advances with Spanish Agency Nod for Cancer Trial
PremiumCompany Announcements
FIL Limited Ends Substantial Holding in Immutep Ltd
Ownership Overview
7.70% Insiders
<0.01% Mutual Funds
0.05% Other Institutional Investors
92.25% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PRRUF FAQ
What was Immutep Ltd’s price range in the past 12 months?
Currently, no data Available
What is Immutep Ltd’s market cap?
Currently, no data Available
When is Immutep Ltd’s upcoming earnings report date?
Immutep Ltd’s upcoming earnings report date is Aug 28, 2024 which is in 123 days.
How were Immutep Ltd’s earnings last quarter?
Immutep Ltd released its earnings results on Feb 27, 2024. The company reported -$0.018 earnings per share for the quarter, missing the consensus estimate of -$0.013 by -$0.005.
Is Immutep Ltd overvalued?
According to Wall Street analysts Immutep Ltd’s price is currently Undervalued.
Does Immutep Ltd pay dividends?
Immutep Ltd does not currently pay dividends.
What is Immutep Ltd’s EPS estimate?
Immutep Ltd’s EPS estimate is -$0.01.
How many shares outstanding does Immutep Ltd have?
Currently, no data Available
What happened to Immutep Ltd’s price movement after its last earnings report?
Immutep Ltd reported an EPS of -$0.018 in its last earnings report, missing expectations of -$0.013. Following the earnings report the stock price went down -4.348%.
Which hedge fund is a major shareholder of Immutep Ltd?
Currently, no hedge funds are holding shares in PRRUF
---
Immutep Ltd Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.49 (104.17% Upside)
$0.49 (104.17% Upside)
Blogger Sentiment
Bullish
PRRUF Sentiment 95%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
41.50%
12-Months-Change
Fundamentals
Return on Equity
-41.05%
Trailing 12-Months
Asset Growth
44.82%
Trailing 12-Months
Company Description
Immutep Ltd
Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
---
PRRUF Stock 12 Months Forecast
Average Price Target
$0.49
▲(104.17% Upside)
Technical Analysis
Best Analysts Covering PRRUF
1 Year
1 Year Success Rate
4/7 ratings generated profit
1 Year Average Return
+85.61%
reiterated a buy rating 11 months ago
Copying Tanushree Jain's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +85.61% per trade.
---